PATENT CLAIM ANALYSIS

Application Number: 16133977
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["607", "120000"]

Abstract:
Representative embodiments of the present invention provide for novel, minimally invasive implantable devices and methods for targeted tissue drug delivery of cardiovascular drugs.

Claim (Index 5):
The device according to  claim 3 , wherein at least one membrane substantially interconnects each of the plurality of electrically conductive elements.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.08696
- Patent Class: 607.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14427607', '10318298', '10679772', '11777283', '10608409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7099852684289174
- 35 USC 102 Novelty (BERT): 0.5518663722340243
- Combined Prediction Score: 0.6941733788094281
- Mean Citation Score: 283.585152
- Max Citation Score: 473.15042
- Similarity Product: 303.8843267632604

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test